Introduction
This document is an update to the 2013 publication of the Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Protocols [1] . Concurrent with this publication, 3 additional task forces will publish documents that should be referred to in conjunction with the present document. The first is a document on the Clinical Indications for CMR [2] , an update of the 2004 document. The second task force will be updating the document on Reporting published by that SCMR Task Force in 2010 [3] . The 3rd task force will be updating the 2013 document on Post-Processing [4] . All protocols relative to congenital heart disease are covered in a separate document [5] .
The section on general principles and techniques has been expanded as more of the techniques common to cardiovascular magnetic resonance (CMR) have been standardized. A section on imaging in patients with devices has been added as this is increasingly seen in day-to-day clinical practice. The authors hope that this document continues to standardize and simplify the patient-based approach to clinical CMR. It will be updated at regular intervals as the field of CMR advances.
General principles

Field strength considerations
Clinical CMR can be performed at different field strengths. 1.5 T systems are currently used for the majority of examinations. An increasing number of studies, however, are being performed at 3 T, with advantages and caveats as noted below. gadolinium enhancement. Furthermore, tagging sequences and 4D flow techniques may benefit from imaging at 3 T. 3. Balanced steady-state free precession (bSSFP) is well established as the default method of choice for cine imaging at 1.5 T. At 3 T, however, the increased sensitivity of bSSFP to off-resonance effects tends to worsen dark banding and flow artifacts. To mitigate these artifacts, it may be necessary to perform careful shimming. In rare cases, patient-specific frequency adjustment may be required. 4 . Devices that have been tested and determined to be safe at 1.5 T may not be safe at 3 T. Please check specific information relating to CMR safety of devices at higher magnetic field strengths. (Please see section 1.6 below.)
Equipment considerations CMR scanner
1. MR scanners for clinical CMR should have field strength of ≥1.0 T; however, the typical field strength employed is 1.5 T with a number of centers using 3 T scanners. 2. A cardiac imaging specific surface coil with multiple coil elements (typically ≥8 elements) is highly recommended, and is required to employ parallel imaging techniques that reduce scan and breathhold times. 3. ECG-gating hardware and software are required, and preferably incorporate vector-cardiographic gating. ECG-gating capabilities should include the ability to perform prospective gating, retrospective gating, and triggered gating techniques.
Software/pulse sequences 1. Required pulse sequences for CMR examinations: cine bSSFP imaging, rapid multi-slice myocardial perfusion imaging, late-gadolinium enhancement (LGE) imaging, phase-contrast flow quantification imaging, and 3D contrast-enhanced angiographic imaging. 2. Parallel imaging capabilities (e.g., Sensitivity encoding (SENSE), simultaneous acquisition of spatial harmonics (SMASH), generalized autocalibrating partially parallel acquisition (GRAPPA)) are highly recommended to reduce scan and breathhold times.
Accessory hardware 1. A CMR-compatible power injector is required for performing rapid myocardial perfusion imaging or contrast-enhanced MR angiographic (MRA) techniques.
Stress agents
Vasodilator stress perfusion testing is more commonly performed than inotropic stress functional testing. Vasodilator stress agents: 1. Volumes and injection rates vary depending on the contrast agent and scan protocol. 2. Injection rates are different for 1 mmol/ml contrast agents (e.g., gadobutrol) and 0.5 mmol/ml agents. As a guideline, divide the given injection rates by a factor of 2 for the 1 mmol/ml formulation. 3. GBCA contrast agents with higher relaxivity require smaller doses.
Safety considerations:
1. More than 300 million GBCA doses have been applied worldwide since 1988 [5] . GBCAs provide crucial medical information in many applications and have an excellent safety profile.
However, nephrogenic systemic sclerosis (NSF) and
long-term gadolinium retention in the brain have resulted in regulatory actions. 3. In 2017 the European Medicines Agency (EMA) decided to suspend the marketing authorizations of all multipurpose linear GBCAs and to continue to use all macrocyclic GBCAs. The United States Food and Drug Administration (FDA) maintained all GBCAs but decided that warnings have to be included in the prescribing information that communicates the greater risk of gadolinium deposition when using linear GBCAs. Additionally, product information updates should incorporate risk mitigation steps and a Medication Guide for each product. 4. Healthcare professionals should consider the retention characteristics of each agent when choosing a GBCA, and particularly for patients who may be at higher risk for gadolinium retention or NSF [6] . 5. The dose of GBCA in all CMR applications should be as low as possible to achieve adequate image quality, and the prescribing information of the products as well as the institutional, regional or national guidelines have to be respected. 6. Noncontrast techniques should be considered as alternatives for contrast-enhanced techniques whenever possible.
Imaging patients with cardiac devices (pacemakers and defibrillators) 
General techniques
Left ventricular (LV) structure and function 1. Scout imagingtransaxial, coronal, sagittalthese are in general single heartbeat acquisitions acquired in 1 breathold. 2. Transaxial (8-10 mm) set of bSSFP or fast spin echo (FSE) images through the chest. These are single-shot, single heartbeat images with a set acquired in 1-2 breathholds. 3. Scout to line up short axis imagescine acquisitions are preferable to single shot as long axis motion and inflow should be visualized a. LV two chamber (vertical) long axis prescribed orthogonal to transaxial scouts aligned through the apex and center of the mitral valve ( Fig. 1 ) b. Four chamber (horizontal) long axis aligned orthogonal to the 2 chamber long axis, passing through the center of the mitral valve and left atrium and continuing through the long axis of the LV. (Fig. 1 ) 4. bSSFP is the method of choice for cine imaging as it provides high SNR and excellent contrast between myocardium and blood pool a. At 3 T, SSFP cine images may be compromised by artifact and spoiled gradient-echo sequences can be considered as an alternative b. Strategies to reduce or move banding artifact include shimming, reducing the TR, and adjusting the RF frequency (frequency 'scout' sequence can be helpful for this) c. Cine images are acquired during a breath-hold.
Breath-hold on expiration provides more consistent positioning but inspiratory breath-hold may be more comfortable and easier to sustain for some patients. 5. bSSFP short axis cine images ( Fig. 2) a. Acquired from the base of the LV through the apex. b. The first short-axis cine plane should be planned using the 4-and 2-chamber long-axis views, and it should be perpendicular to the long-axis of the body of the LV. This plane might not always be parallel to the mitral valve plane.
c. Slice thickness 6-8 mm, with or without 2-4 mm interslice gaps (to make a total of 10 mm). d. Temporal resolution ≤45 ms between phases to optimize evaluation of wall motion e. Parallel imaging or compressed sensing used as available to shorten scan time. 6. bSSFP long axis cine images a. The 4-chamber long-axis view is prescribed from the 2-chamber long-axis view through the apex and center of the mitral and tricuspid valves. This can be modified and/or crosschecked on basal short-axis views, to have the plane cross the acute margin of the right ventricular (RV) free wall and perpendicular to the interventricular septum. b. The 2-chamber LV view is prescribed from the vertical long-axis scout already acquired with modification to pass through the anterior and inferior myocardial walls. c. The 3-chamber LV view is prescribed passing through the apex, the center of the mitral valve and aligned with the center of LV outflow tract (LVOT) to aortic valve, as seen on a basal short axis cine. (Fig. 3 ) d. Optionalmore than 3 long axis views can be obtained. 7. Real-time cine imaging (optional) a. To assess ventricular interdependence or for patients with irregular rhythms or inability to breathhold that preclude standard gated cine imaging, real-time cine imaging (using a variety of different k-space acquisition approaches) may be used to assess LV function. b. Temporal resolution ≤60 ms between phases is preferable if available. c. Absolute LV volume quantification is not always possible using real-time cine imaging as quantitation is typically less accurate and precise. as an optional second set or as backup for patients with irregular heart beat, and/or difficulty breath holding. 2. Need at least 10 min wait after GBCA injection (for dosing see Table 1 ). Note -the delay may be < 10 min if lower gadolinium doses are used as blood pool signal falls below that of late enhanced myocardium. Images are generally acquired during diastolic standstill. Also noteif stress and rest perfusion imaging is performed, the wait should only be approximately 5 min after the 2nd injection of contrast. 3. Same views as for cine imaging (short-and longaxis views) ( Fig. 6 ) 4. Slice thickness, same as for cine imaging 5. In-plane resolution,~1.4-1.8 mm Fig. 5 Three short axis images (apex at top, mid in the middle, and base at the bottom) acquired during the first pass of gadolinium based contrast agent (GBCA) through the myocardium. Note the perfusion defect in the lateral wall in the mid and basal slices Fig. 6 Four-chamber long axis inversion recovery gradient echo late gadolinium enhanced image from a patient with a 50-75% transmural apical septal and apical myocardial infarction 6. Acquisition duration per R-R interval below 200 ms, but should be less in the setting of tachycardia to avoid image blurring. 7. Inversion time (TI) set to null normal myocardium.
A "TI scout", which is a cine sequence with an inversion pulse that is played at the beginning of the R-wave, can be used as a rough guide to set the TI. However, the TI scout sequence usually does not have the identical readout parameters as the segmented LGE sequence and hence the correct TI may be up to 50 ms different between the two sequences. Alternatively, a PSIR sequence can be used, which obviates the need for a precise setting of the TI. a. Imaging using a "long-inversion" time (~550 ms at 1.5 T and 850 ms at 3 T) can be helpful in distinguishing no-reflow zones or mural thrombus from viable myocardium. b. Imaging using a short inversion time (~200 ms) and PSIR can be helpful in distinguishing subendocardial scar. 8. Read-out is usually every other heartbeat, but should be modified to every heartbeat in the setting of bradycardia (< 60 bpm), and every third heartbeat in the setting of tachycardia (> 100 bpm) or arrhythmia. 9. Dark-blood LGE imaging (optional) a. If available, flow independent "dark-blood" techniques may be helpful in differentiating subendocardial LGE from blood-pool compared with conventional LGE imaging. b. Settings, except for inversion time (which is set according to the specific sequence that is used), are similar to conventional LGE imaging.
Stress perfusion (vasodilator)
1. LV structure and function (alternatively this can be performed between stress and rest perfusion, although performance immediately after GBCA infusion may reduce the contrast of the bloodendocardium interface) 2. Adenosine stress perfusion imaging. Optioninitial adenosine infusion may be performed with the patient outside the bore of the scanner, and move the patient inside for the second half of the infusion. a. First pass perfusion b. During last minute of adenosine, GBCA is injected c. Use same approach for dipyridamole 3. Alternatively: Regadenoson stress perfusion imaging (bolus injection of 0.4 mg). a. First pass perfusion b. Approximately 45-60 s after regadenoson injection, inject GBCA 4. Rest Perfusion a. Need at least 10 min wait for to wash out from stress perfusion imaging. During this period cine imaging can be completed (e.g., long-axis views). b. Perfusion imaging repeated without adenosine/ regadenoson using same dose of GBCA c. Depending on institutional policy and experience, rest perfusion can be omitted. There is increasing data that rest scanning adds little information and should be omitted whenever possible. d. Additional GBCA may be given as needed for late gadolinium enhancement (for a total of 0.1-0.2 mmol/kg) 5. Late Gadolinium Enhancement a. Need to wait at least 5 min after rest perfusion if performed 6. Optional -Quantitative perfusion imaging a. Consider using a dual bolus or dual sequence approach to reduce the effect of nonlinearity between contrast agent concentration and signal intensity. b. Consider adding proton density images before the contrast injection. This can be used as baseline correction for full quantification but requires specific scanner software that may not be available on all scanners.
Stress function (dobutamine or exercise)
1. LV structure and function 2. Dobutamine stimulation (See 1.2, Stress agents) a. Increase the dobutamine in increments of 10 μg/ kg body weight/minute every 3 min starting at 10 μg/kg body weight/minute until the target heart rate [85% x (220-age)] is reached. b. Add atropine in 0.5 mg incremental doses if the heart rate response is inadequate. c. Repeat 3 short-axis and 3 long-axis cine views during each increment. These can be obtained with breathhold or real-time at lower heart rates, but at higher heart rates, breathhold acquisitions are recommended due to the ability to improve the temporal resolution. d. Continuous ECG monitoring and blood pressure measured during each stage. e. View cine loops immediately after they are acquired. f. Adapt the bSSFP cine sequence to optimize temporal resolution as needed as the heart rate increases.
g. Stop the test for a new wall motion abnormality, a serious side effect, or achievement of the target heart rate. 3. Alternativetreadmill exercise with a CMRcompatible treadmill in the scanner room with imaging (3 short-axis and 3 long-axis cine views) performed at baseline and after peak exercise. The temporal resolution of the bSSFP cine sequence will need to be shortened for the post-exercise scans. 4. Alternativesupine bicycle exercise with a CMR-compatible ergometer in the scanner room/ scan table with imaging (3 short-axis and 3 longaxis cine views) performed at baseline and after peak exercise. The temporal resolution of the bSSFP cine sequence will need to be shortened for the post-exercise scans.
Blood flow quantitation 1. Usually performed as part of other cardiovascular protocols. Available scout images can be used. Best if vessel of interest is depicted in two orientations or MRA can be reformatted on the scanner for further planning (e.g., additional bSSFP, contrast enhanced (CE)-MRA, or single-shot black blood scouts are helpful) 2. Sequence: one-direction ("through-plane") motionencoded cine gradient echo sequences are typically applied (Fig. 7 ) 3. For optimal results, the imaging plane should be a. centered in the vessel of interest b. aligned orthogonally to the expected main blood flow direction in two spatial directions c. centered in the iso-center of the scanner 4. Imaging parameters: slice thickness 5-8 mm; inplane resolution at least 1/10th of the vessel diameter. Velocity encoding sensitivity (V enc ) has to be adapted to the expected velocitiesthe lowest available velocity without aliasing should be used. After each scan, phase difference images have to be checked for aliasing. If aliasing is present, V enc settings need to be increased accordingly. If available, a velocity scout may allow optimal setting of the V enc .
A temporal resolution of ≤50 ms between phases is
preferable. The temporal resolution should be calculated as the time between frames that are actually acquired. Many vendors allow the creation of extra frames by image interpolation, which only improves the temporal resolution artificially. Retrospective gating covers the entire cardiac cycle and is more convenient, but may obscure inaccuracies related to arrhythmia. 6. For read-out, k-space segmentation over multiple heart beats is used to limit the acquisition time to a breath hold period. Alternatively, navigatorbased non-breathhold techniques can be applied to improve the temporal or spatial resolution if necessary. Also, free-breathing approaches with multiple signal averages (NEX, NSA) have been proven useful in patients with limited breathholding capabilities. 7. The echo time (TE) should be set to shortest, particularly when stenoses are imaged. 8. If available, consider a 4D Flow CMR acquisition.
4D Flow CMR is becoming more readily available, it has been shown to provide unique insight in and select clinical settings. Fig. 7 Velocity-encoded flow quantitation sequence acquired at the sinotubular junction in a patient with aortic stenosis. The initial sequence (Magnitude [left] and velocity [center] images) was acquired with a VENC of 250 cm/sec, which was too low, as aliasing (red arrow) is evident. The sequence was reacquired (right) with a VENC upward adjusted to 350 cm/sec, and aliasing is no longer present
Advanced tissue characterization
The area of tissue characterization is a rapidly developing field and the pulse sequences available on different vendor platforms vary significantly. The acquisitions are similar between 1.5 T and 3 T, although measured values are often different and may also be site specific. Thus, listed below are general guidelines only as standardization continues to advance. Normal values should be developed at individual institutions. Manual shimming prior to imaging should be considered for optimal performance, particularly at 3 T. For detailed recommendations, please see [7] . a. T2* images should be obtained prior to contrast administration. b. The pulse sequence is a single breathhold, gradient-echo, multi-echo scan with a series of 6-9 echo times beginning at~2 msec and extending to~18 msec, with each echo iteratively spaced by~2 msec. A delay time of 0 msec after the R wave typically is used. c. Optional -In patients with severe iron deposition a pulse sequence with shorter echo spacing could be helpful to accurately determine T2* values: a series of 6-9 echo times beginning at~1 msec and extending to~12 msec, with each echo iteratively spaced by~1 msec. d. A single mid-ventricular short-axis image is acquired. e. Slice thickness of 8-10 mm; in-plane resolution, 1.6-3.0 mm f. (Optional) An imaging sequence similar to the above, though non-ECG-gated, is acquired in the axial orientation through the mid portion of the liver to evaluate hepatic iron deposition. The absence of ECG-gating will allow for closer spacing of iteratively advanced echo times, and therefore a greater number of echoes will be acquired.
Rapid protocols
Rapid protocols have been developed for 1.5 T scanners and have been successfully applied for cardiomyopathy evaluations. In addition to cardiomyopathies, additional indications for which rapid protocols could be applied include chronic ischemic heart disease to assess viability and hypertensive heart disease, This protocol minimizes exam times and maximizes cost-effectiveness. The protocol as tested is as follows:
1. Localizers, 2 chamber scout image, 3 slice short axis stack scout images, and a transverse dark blood single shot FSE stack for anatomic evaluation. 2. Cine imaging: four, two, three chamber and aortic valve segmented k-space cine acquisitions.
3. Contrast injection of appropriate dose of GBCA 4. Cine imaging: short-axis cine stack (7-mm slice thickness, 3 mm interslice gap) segmented k-space cine acquisitions. 5.
LGE imaging:
a. Optional sequence to determine optimal inversion time b. Segmented k-space LGE acquisitions in standard long axis and short axis planes with phase sensitive and magnitude reconstructions.
Disease specific protocols -
Ischemic heart disease
CMR can be uniquely helpful in differentiating between ischemic and various nonischemic forms of acute myocardial injury. Even after the diagnosis of myocardial infarction (MI) has been made, CMR may be helpful in identifying residual viability, stunning, and microvascular damage. In addition, post-MI sequelae, including LV thrombus, LV aneurysm or pseudoaneurysm formation, and pericarditis are easily identified.
Acute MI or acute coronary syndromes 1. LV structure and function 2. Advanced tissue characterization -optional, although frequently used to assess edema/ inflammation that can accompany acute necrotic injury 3. Optional -First pass perfusion (only at rest).
Consider stress if culprit vessel has already been revascularized to evaluate for ischemia in the noninfarct territories 4. Optional -Early gadolinium enhancement, i.e. within the first 1-3 min after contrast infusion to look for early microvascular obstruction (MVO) 5.
LGE
Chronic ischemic heart disease and viability
General purpose of CMR is to document baseline LV morphology, contractility, viability, and (often) ischemia. Follow-up imaging can be helpful in assessing changes in ventricular remodeling as well as scar and/or ischemia burden following clinical events and/or medical therapeutic interventions. Detection of LV thrombi is also important.
1. LV structure and function 2. Advanced tissue characterization -optional, although may be used to exclude other potential pathologies 3. Optional -low dose dobutamine with 5-10 min infusion of 2.5-10 μg/kg/min of dobutamine to assess contractile reserve identified as improvement in wall thickening 4. Optional -vasodilator stress-rest perfusion or high dose dobutamine functional imaging to determine the presence of inducible ischemia 5.
Nonischemic heart disease Hypertrophic cardiomyopathy (HCM)
Goals of imaging HCM include measuring LV mass and volumes, global function, and maximal wall thickness (by cine imaging), assessing scar (LGE and T1 mapping) and measuring the LVOT gradient if present.
1. LV structure and function 2. LVOT flow imaging using bSSFP cine imaging in a 3-chamber view examining for turbulence and systolic anterior motion of the mitral valve or chordae, and phase velocity measurements for gradient (using either in-plane phase-velocity imaging in the 3-chamber view, or through plane phase-velocity measurements perpendicular to the LVOT) if LVOT obstruction is present 3. Advanced tissue characterization -optional, although frequently used 4. Optionalconsider vasodilator stress perfusion if underlying ischemia is being considered 5.
Hypertensive heart disease
Goals of imaging hypertensive heart disease include assessing LV mass, wall thickness, volumes, global function (by cine imaging), and scar (LGE and T1 mapping).LV structure and function 1. Advanced tissue characterization -optional, although frequently used 2. Optional -vasodilator stress-rest perfusion or high dose dobutamine functional imaging to determine the presence of inducible ischemia 3. Optionalaortic imaging and renal MRA to exclude secondary causes of hypertension 4.
Left ventricular non-compaction
Goals of imaging LV noncompaction include assessing trabeculations and measuring the wall thickness of compacted and noncompacted segments as well as LV volumes and global function, and assessing for thrombi and scar (LGE) 1. LV structure and function 2. Advanced tissue characterization -optional, although frequently used to exclude other potential etiologies. 3. Optional -vasodilator stress-rest perfusion or high dose dobutamine functional imaging to determine the presence of inducible ischemia 4.
Recreational drug-induced cardiomyopathies
Goals of imaging recreational drug-induced cardiomyopathy include measuring LV mass, volumes, and global function (by cine imaging), and assessing scar (LGE and T1 mapping).
1. LV structure and function 2. Advanced tissue characterization -optional, although frequently used 3. Optional -vasodilator stress-rest perfusion or high dose dobutamine functional imaging to determine the presence of inducible ischemia 4.
Post-heart transplantation
Goals of imaging post-heart transplantation cardiomyopathy include measuring LV mass, volumes, and global function (by cine imaging), and assessing scar (LGE and T1 mapping) and inflammation/edema (T2w imaging or T2 mapping). a. Transaxial slices spanning from level of proximal main pulmonary artery down to the middle of the right atrium (entire cardiac coverage if desired). Slice thickness 1--1.5 mm; acquired spatial resolution in-plane of 1.0 mm or less. Fat suppression is typically used. b. Slicestypically 50--80, as needed to encompass vessels of interest c. Adjust trigger delay and acquisition window according to observed quiescent coronary period d. Parallel acquisition preferred e. Navigator placed over the right hemi-diaphragm f. Optional -GBCA may increase vessel conspicuity if the contrast agent was administered previously as part of the scan. Due to the relatively long scan time of coronary artery imaging with CMR, a bolus injection is not recommended. 3. Optionala. Breathhold techniques if poor image quality or navigators unavailable or of poor quality b. T2-prepared sequence may be useful to suppress myocardial and venous signal
Pulmonary vein evaluationpre-and post-ablation 1. LV structure and function (optional) 2. Breathheld 3D contrast-enhanced MRA performed in the coronal projection encompassing the pulmonary veins and left atrium (greater anterior coverage if breathholding permits) a. Optionaloblique plane centering the pulmonary veins can reduce slab thickness and therefore breath hold time but will lead to less coverage of the left atrium b. Optional -ECG-gating. When patient has irregular rhythm, readout should be synchronized with systole (i.e. no trigger delay) c. 2-3 volumetric acquisitionsone pre-contrast (for subtraction), one during the first pass of contrast administration, one (optional) after contrast administration d. Time-resolved multiphase MRAacquisition and contrast started simultaneously; this can provide isolated pulmonary venous phase image for reconstruction and integration with ablation mapping software e. GBCA (0.1-0.2 mmol/kg) injected at 2-3 ml/s f. Slice thickness 1-2 mm; acquired spatial resolution in-plane 1-1.5 mm g. Slicestypically 60-80, as needed to encompass region of interest approximately 5 mm superior to the valve plane, at end diastole. Retrospective acquisition is essential to cover the entire cardiac cycle ii. Stenosis 1. Velocity encoded imaging (through plane encoding) in a plane parallel to the pulmonic valve and at the point of peak flow disturbance identified on a long-axis cine image through the pulmonic valve 2. Alternatively, Velocity encoded imaging (in-plane encoding) along an imaging plane parallel to and in line with the pulmonic valve jet of flow disturbance Pericardial disease 1. LV structure and function 2. T1 or T2-weighted FSE images (optional, with or without fat saturation) a. 2--3 representative long-axis images and 3--4 representative short-axis images to measure pericardial thickness (normal ≤3 mm) b. If pericardial cyst is suspected, refer to masses protocol 3. Optional -iIf regions of thickened pericardium noted -GRE myocardial tagged cine sequences to demonstrate presence or absence of epicardial/ pericardial slippage (2--3 long axis images and 1--2 short axis images) 4. Real-time imaging during dynamic breathing manoeuvres is valuable for evaluation of ventricular interdependence a. Mid-ventricular short-axis plane is preferred b. Cine imaging temporal resolution is preferably below 60 ms c. Patients are instructed to breathe deeply in and out and the total imaging period should be at least 2 complete respiratory cycles d. Abnormal septal motion (early diastolic septal flattening or inversion) during onset of inspiration is consistent with a constrictive physiology 5.
LGE a. Acquisition with and without fat saturation is helpful to distinguish pericardial inflammation from epicardial or pericardial fat
Cardiac and paracardiac masses, including thrombi
